Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

MRNA holding history

Moderna, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MRNA overviewAll 13F holders of MRNAFull Q2 2026 holdings

Shares (Q2 2026)
24,951
Value
$1.75M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of MRNA by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202624,951$1.75M<0.1%−641,581−96.3%ReducedHolders
Q1 2026666,532$33.9M<0.1%−4,516,227−87.1%ReducedHolders
Q4 20255,182,759$152.8M0.1%−963,615−15.7%ReducedHolders
Q3 20256,146,374$158.8M0.1%−1,317,181−17.6%ReducedHolders
Q2 20257,463,555$205.9M0.2%+1,827,404+32.4%AddedHolders
Q1 20255,636,151$159.8M0.2%+3,867,436+218.7%AddedHolders
Q4 20241,768,715$73.5M0.1%+1,509,591+582.6%AddedHolders
Q3 2024259,124$17.3M<0.1%+259,124NewHolders
Q2 20240$00.0%−48,022−100.0%Sold outHolders
Q1 202448,022$5.12M<0.1%−314,155−86.7%ReducedHolders
Q4 2023362,177$36.0M0.1%+303,845+520.9%AddedHolders
Q3 202358,332$6.03M<0.1%−20,175−25.7%ReducedHolders
Q2 202378,507$9.54M<0.1%−189,573−70.7%ReducedHolders
Q1 2023268,080$41.2M0.1%−298,928−52.7%ReducedHolders
Q4 2022567,008$101.8M0.2%+294,842+108.3%AddedHolders
Q3 2022272,166$32.2M0.1%+245,352+915.0%AddedHolders
Q2 202226,814$3.83M<0.1%−1,227,130−97.9%ReducedHolders
Q1 20221,253,944$216.0M0.3%+240,949+23.8%AddedHolders
Q4 20211,012,995$257.3M0.3%+259,232+34.4%AddedHolders
Q3 2021753,763$290.1M0.4%−920,545−55.0%ReducedHolders
Q2 20211,674,308$393.4M0.5%+1,616,152+2,779.0%AddedHolders
Q1 202158,156$7.62M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.